We’re getting down to the numbers! TOMORROW on The HighWire | July 27, 2023
The HighWire with Del Bigtree
Novo Nordisk's Stock Dips: CagriSema Trial Results Shock Investors!
WealthyBusiness
Women SUE Ozempic Makers After Contracting LIFE THREATENING Illness!
Don Khan Swaylo
Michael Burton & Prof. Matthias von Herrath - Diabetes Research Inst - Biologically Curing Diabetes
ProgressPotentialAndPossibilities
Pharmaceutical and Biotech Industry Thought Leaders Stream On Progress, Potential and Possibilities
ProgressPotentialAndPossibilities
Novo Nordisk's Rollercoaster Ride: Challenges & Triumphs!
WealthyBusiness
Merck's $2B Bet on Weight-Loss Pill!
Wealthy Business
Impending Mounjaro shortage & FDA approval for obesity!
coloradomedicalsolutions
NVO Stock: The Next Big Thing?
Allviantho
Novo Nordisk's New Obesity Drug: Game Changer? #shorts
WealthyBusiness
When Weight-Loss Drugs Leave You Paralysed | Vantage with Palki Sharma
Firstpost